Faecal calprotectin in children with chronic gastrointestinal symptoms

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 12, 2005, Pages 1855-1858

  Bremner, Alan ^a   Roked, Sohere ^a   Robinson, Rebecca ^a   Phillips, Ian ^a   Beattie, Mark ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Calprotectin; Diagnostic tests; Inflammatory bowel disease

Indexed keywords

C REACTIVE PROTEIN; CALPROTECTIN;

ADOLESCENT; ARTICLE; CHILD; CONSTIPATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENTERITIS; FECES ANALYSIS; FECES LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; CHRONIC DISEASE; FECES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE;

EID: 31544450583     PISSN: 08035253     EISSN: 15023869     Source Type: Journal    
DOI: 10.1080/08035250500254639     Document Type: Article

References (14)

1. Bunn SK, Bisset WM, Main MJC, Golden BE. Faecal Calprotectin: validation as a non-invasive marker of bowel inflammation in childhood inflammatory bowel disease. JPGN 2000;33:14-22.
2. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. JPGN 2003;37:468-72.
3. Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatrica 2002;91:45-50.
4. Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, et al, Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Digestive and Liver Disease 2004;36:467-70.
5. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
6. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506-13.
7. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58(2):176-80.
8. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand. J. Gastroenterol 2000;35: 64-9.
9. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. JPGN 2001;32:171-7.
10. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al, Development and validation of a pediatric Crohn's disease activity index. JPGN 1991;12:439-47.
11. Beattie RM, Nicholls SW, Domizio P, Williams CB, Walker-Smith JA. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. JPGN 1996;22:373-9.
12. Shah DB, Cosgrove M, Rees JI, Jenkins HR, The technetium white cell scan as an initial imaging investigation for evaluating suspected childhood inflammatory bowel disease. JPGN 1997;25:524-8.
13. Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson DF, Kristjansson K, et al, Subclinical Intestinal Inflammation : An Inherited Abnormality in Crohn's Disease Relatives? Gastroenterology 2003;124:1728-37.
14. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al, Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003;35:642-7.